Category: Uncategorized

Dr Noel Chambers, CEO, The National Foundation for Medical Research and Innovation discusses how funders of research should consider how to influence important activities beyond research that enable translation and impact.

VIEW POST

Highlighting some of the advances made in NFMRI funded medical research.  See more in our annual report.       Prof Michael Good AO Institute for Glycomics, Griffith University Field: Rheumatic heart disease (Group A Streptococcus) Innovation: Potential new vaccine Professor Michael Good AO was awarded an NFMRI grant commencing in 2015 to support the production […]

VIEW POST

Could this be a reality?   We all know that not all good ideas gain traction and become reality. This is true for inventors, for business, for things around the home and for medical research. Discoveries and good ideas that are never disclosed and disappear without a trace may later be rediscovered and lead to future […]

VIEW POST

Written by Professor Ian Smith, Monash University Vice-Provost (Research and Research Infrastructure), A number of universities across the globe are recognising the value of Investment in world-class research infrastructure in the form of technology research platforms (TRP’s). These investments are helping to take research and industry collaborations to a new level and also helps create local […]

VIEW POST

Professor Michael Good AO talks about NFMRI funding and his research into a new Strep vaccine for rheumatic heart disease and deep tissue infections   The ‘Valley of Death’ grant that we recently received from the National Foundation for Medical Research and Innovation (NFMRI) has been a Godsend to our streptococcal vaccine project. Whist there […]

VIEW POST

Forbes Magazine has written an interesting article “Where Does All That Biotech Venture Capital Go?” around the Biotechnology Venture Capital industry and an analysis by BIO.

VIEW POST

Assuming both are important where do you think priority should lie?

VIEW POST

Measuring success when supporting biomedical research can be difficult.  This is particularly relevant if there is no predetermined agreement of what success looks like or no strategy to guide how you contribute to the larger picture. Often governments, researchers and the community use terms such as ‘bench to bedside’ (beginning and end) when considering the […]

VIEW POST

It’s good to give

23rd September 2014

Since 2001, wealthy Australian families have been increasingly taking advantage of Private Ancillary Funds (PAFs) as a vehicle to structure their giving.  What these funds provide is no surprise; tax deductibility paired with the ability to custom-design your own support to the causes chosen by you and your appointed directors (which are often family members). […]

VIEW POST

make-a-donation

partner-enquiry

thinking-out-land

Loading

Looking beyond the research and considering translational needs when funding research. How well are your expectations, application and review processes, measures of success and funding strategy aligned with the next steps for translation?

Thank you for voting
You have already voted on this poll!
Please select an option!